CYTOVALE INC
CYTOVALE INC is a federal contractor, registered under UEI TG7HM4HD8594 and CAGE code 6PS42. It has been awarded $15,352,150 across 11 federal contracts. Primary work spans Research and Development in Biotechnology (except Nanobiotechnology), Unknown NAICS, and Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Top awarding agencies include Department Of Health And Human Services, National Science Foundation, and Department Of Health And Human Services (hhs).
Contact Information
Registration and classification details
Registration
UEI Code
TG7HM4HD8594CAGE Code
6PS42Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Cytovale Inc. specializes in advanced research and development for clinical diagnostics, with a focused expertise in deep-learning-driven sepsis monitoring systems and biomarker analysis for infection severity stratification. The company develops and validates AI-powered diagnostic tools designed fo...
Cytovale Inc. specializes in advanced research and development for clinical diagnostics, with a focused expertise in deep-learning-driven sepsis monitoring systems and biomarker analysis for infection severity stratification. The company develops and validates AI-powered diagnostic tools designed for real-time clinical decision support, particularly in acute care environments. Their technical capabilities encompass algorithm development for physiological signal interpretation, clinical validation protocols, and integration of at-home monitoring platforms with hospital-based electronic health records. Cytovale’s work bridges computational biology and clinical epidemiology, emphasizing scalable, non-invasive solutions that reduce diagnostic delays and improve resource allocation in sepsis management. The contractor has established a consistent relationship with the Department of Health and Human Services, delivering R&D services that advance public health response capabilities. Their engagements center on validating novel diagnostic technologies for deployment in federal healthcare systems, particularly through HHS agencies focused on infectious disease surveillance and emergency preparedness. This pattern indicates a trusted partnership in translating laboratory innovations into clinically actionable tools under federal oversight. Cytovale operates primarily within NAICS 541714 and 541715, reflecting deep specialization in biotechnology R&D and life sciences innovation outside nanotechnology. Their market positioning is niche but impactful, targeting the intersection of artificial intelligence, clinical microbiology, and point-of-care diagnostics. The company is not certified under any federal small business or diversity programs and is headquartered in San Francisco, CA, leveraging the region’s biotech ecosystem to advance next-generation diagnostic platforms. Their work supports the broader mission of improving outcomes in critical care through data-driven, evidence-based clinical tools.
Key Performance Metrics
Awards Count
All time
Active
Currently performing
Completed
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
